Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Documenti analoghi

• Clinical Use of Comprehensive Genomic Profiling Tests in Intrahepatic Cholangiocarcinoma: A Single‐Center Retrospective Study
  di: Makiko Urabe, et al.
  Pubblicazione: (2025)
• Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden‐High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment
  di: Yugo Kai, et al.
  Pubblicazione: (2026)
• Comparison of sedation with pentazocine or pethidine hydrochloride for endoscopic ultrasonography in outpatients: A single‐center retrospective study
  di: Makiko Urabe, et al.
  Pubblicazione: (2024)
• Rechallenge of Atezolizumab Plus Bevacizumab Therapy in Patients With Unresectable Hepatocellular Carcinoma
  di: Yuichiro Suzuki, et al.
  Pubblicazione: (2025)
• Clinical Significance of Anti‐Atezolizumab Antibodies in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
  di: Keishi Ouchi, et al.
  Pubblicazione: (2026)